Peter Ernst focuses his practice on mergers and acquisitions, private equity, and general corporate advisory work. 

Peter represents private equity funds and their portfolio companies in mergers and acquisitions, growth equity investments, and other strategic transactions.

Peter’s experience includes representing: 

  • Empyrean Solutions in its significant investment from Hg*
  • Serent Capital in its significant investment in Casino Cash Trac*
  • Pulmokine in its acquisition by XOMA Royalty* 
  • BV Investment partners in its acquisition of Balance Partners*
  • Sunstone Partners in its growth investment in Accuhealth*

*Matter handled prior to joining Latham

Thought Leadership

“Disparities in Exposure to Television Advertising of Sugar Sweetened and Non-Nutritive Sweetened Beverages Among U.S. Adults and Teens, 2007-2013,” co-author, Preventative Medicine, September 2021

Bar Qualification

  • Massachusetts

Education

  • JD, Harvard Law School, 2023
  • BS in Policy Analysis and Management, Cornell University, 2019
    with distinction

Languages Spoken

  • English